News & events

CRIS blog: Inpatient use and area-level socio-environmental factors in people with psychosis

Dr Margaret Heslin is a research fellow and honorary lecturer in King’s Health Economics at the Institute of Psychiatry, Psychology & Neuroscience at King's College London.

By NIHR Maudsley BRC at 13 Jun 2018

Cannabidiol (CBD) could represent a ‘new class of treatment’ for psychosis

A constituent of cannabis could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial.

By NIHR Maudsley BRC at 14 Dec 2017

Brain stimulation may improve cognitive performance in people with schizophrenia

Brain stimulation could be used to treat cognitive deficits frequently associated with schizophrenia, according to a new study supported by the NIHR Maudsley Biomedical Research Centre (BRC).

By NIHR Maudsley BRC at 25 Jul 2017

Study reveals for first time that talking therapy changes the brain’s wiring

Study shows for first time that Cognitive Behaviour Therapy results in long-term changes to the brain's wiring.

By NIHR Maudsley BRC at 17 Jan 2017

Research blog: Defining treatment resistance in schizophrenia

Research blog: Professor Oliver Howes on defining treatment resistance in schizophrenia.

By NIHR Maudsley BRC at 8 Dec 2016
There are 10 items on 2 pages.